Concepedia
Statistics
Publications
76
Citations
5.7K
H-Index
38
Active since
2006
Affiliations
University of Cambridge(Current)
University College London
MRC Cognition and Brain Sciences Unit
University of Oxford
University of Manchester
Thomas Cope is an author at University of Cambridge specializing in neurology, neurodegenerative diseases, and neuroscience.
Publications per year
2006–2025
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +6
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
Katrina Moore, Jennifer Nicholas, Murray Grossman et al. · The Lancet Neurology · 2019 · 311 citations · Full text
Medicine, Genetics, Neurology +17
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
1–5 of 76